Quantcast

Posts related to ‘Hepatitis B’

Analyst Sees 55% Upside in Small Biotech

Posted: November 28, 2012 at 10:49 am

Idenix Pharmaceuticals Inc. (NASDAQ: IDIX) was covered this morning in our analyst upgrades and downgrades daily summary, but call is worth a closer look. Deutsche Bank initiated the small biotech with ...
Read Full Story »

Gilead Sciences and Celgene Score Major Drug Wins

Posted: November 12, 2012 at 9:03 am

When biotech stocks become as big as some of the second-tier drug stocks, it represents billions of dollars worth of value when these move 5% or 10%. That is exactly ...
Read Full Story »